Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study Evaluating Fentanyl Transmucosal in the Prevention of Pain Induced by Mobilization During Radiotherapy in Patients With Bone Metastasis

NCT02426697 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT02426697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02426697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study Evaluating Fentanyl Transmucosal in the Prevention of Pain Induced by Mobilization During Radiotherapy in Patients With Bone Metastasis
Lead sponsor
Centre Henri Becquerel
Phase
Phase 3
Overall status
Completed
Start date
May 22, 2015
Completion date
April 30, 2020
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastasis